A Global Check-Up on Antenatal Care for Preterm Babies
A major international study reveals stark disparities in the use of two key, evidence-based antenatal interventions: magnesium sulfate and steroids. Analyzing data from over 45,000 preterm infants across 11 countries, researchers found that while usage of antenatal steroids is relatively high, the administration of magnesium sulfate—which protects against cerebral palsy—varies dramatically. In high-income countries like Ireland and the UK, more than 80% of eligible mothers receive it, compared to just 33-44% in middle-income countries like South Africa and the UAE. The analysis, supplemented by a literature review, shows this treatment gap has persisted over time, highlighting a significant inequity in global perinatal care.
Why it might matter to you:
This research quantifies a critical implementation gap in preventive maternal healthcare, directly relevant to public health strategies aimed at reducing long-term disability. For professionals focused on health behavior and chronic disease prevention, it underscores that proven interventions can fail at the point of delivery due to systemic factors. The findings argue for a shift in focus from merely establishing clinical guidelines to understanding and addressing the barriers—whether logistical, educational, or resource-based—that prevent their equitable adoption worldwide.
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
